1Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood, 1990; 75:1011 - 1016
2Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene:relevance to disease. J Leukoc Biol, 1999; 66:562- 566
3Brinkman BM, Huzinga TW, Kurban SS, et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol.1997; 36:516 - 521
4Deeg HJ, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med, 1984; 35:11 - 24
5Kernan NA, Collins NH, Juliano L, et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with deve-lopment of graft-v-host disease. Blood, 1986; 68:770 - 773
6Siegert W, Josimovic-Alasevic O, Schwerdtfeger R, et al. Soluble interleukin 2 receptors in patients after bone marrow tran-splantation. Bone Marrow Transplant, 1990; 6: 97 - 101
7Ochs LA, Blazar BR, Roy J, et al. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Trans-plant, 1996; 17:1085- 1092
8Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol, 1997; 34:391 - 399
9Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphisrn. J Invest Dermatol. 2000; 114:1180- 1183
10Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA, 1999; 282:561- 568
